Roche

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. With the first half of 2020 in the books and the second-quarter earnings season in full swing, it looks as if global markets are starting...

COVID-19 coronavirus made us realize that health should always be our top priority. Here are some companies working to make the world a better place after the pandemic.  AbbVie Inc – Botox To The Rescue With unappreciated potential, the stock of this big drugmaker has stellar...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. After weathering a historically volatile month in March, trading activity on OTC Markets abated somewhat in April, reflecting a relative...

Roche Holding AG (OTC: RHHBY) is shipping COVID-19 test kits approved under emergency use authorization (EUA) by the FDA. What Happened Roche’s Sars-CoV-2 Test for COVID-19 has begun shipping to hospitals and laboratories across the U.S. The test will enable high-volume, automated...

This post is from Benzinga's Partner Content team As August winds down, so too does the second quarter earnings season. So, we thought we’d take a look at what some of the companies with securities that trade on OTC Markets had to say about their June quarters. For the sake of brevity...

This post is from Benzinga's Partner Content team More than 4 billion shares—or $7.7 billion—exchanged hands on the OTCQX Best Market and OTCQB Venture Market in July. These were the most active individual securities on each of the top tiers of OTC Markets.  OTCQX Market ...

With the second half of 2019 well underway, let’s take a look back at 10 numbers that defined the activity on OTC Markets through the first six months of the year.  1) 187 The number of securities that joined the OTCQX and OTCQB Markets in the first half of the year—60 joined...

As we highlighted last month, preferred shares of Fannie Mae and Freddie Mac experienced dramatic increases in dollar trading volume to start 2019. That was not the case in February however, as dollar volume in the mortgage liquidity providers receded back to normal levels. While different share...

Research-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) announced Monday it has named Daniel O'Day as its chairman of the board and CEO, effective March 1. What Happened O'Day joins Gilead after more than three decades of experience at Roche Holdings AG Basel ADR (OTC...

Switzerland-based Novartis AG (ADR) (NYSE: NVS) owns a roughly $14 billion stake in rival Roche Holding Ltd. (ADR) (OTC: RHHBY) and is actively shopping for buyers to acquire its stake. According to Reuters, Novartis has been working with bankers to explore the sale of its stake in Roche and would...

On Tuesday, the Iraqi government held its first session with its new parliament including representation from Sunnis and Kurds. However, both groups walked out of the meeting after the Shi’ite government did not announce Prime Minister Nouri al-Maliki’s replacement. Meanwhile,...

Drug manufacturing has become a lot like Hollywood lately -- they’ve both become all about blockbusters. After all, it's the big sellers, or the blockbusters, that drug executives and Hollywood alike aspire to develop. The top 10 best-selling drugs globally, like today’s comic...

Here's a look at the top tickers trending on StockTwits.com Tesla: Robust sales in California According to Bloomberg, Tesla Motors' (NASDAQ: TSLA) Model S sedan ranks third place among luxury cars in California in 2013. According to a market report from the California New Car Dealers...

Shares of Alexion (NASDAQ: ALXN) spiked higher when Bloomberg reported that the pharmaceutical company will be working with Goldman Sachs (NYSE: GS) on a potential takeover by Roche (OTC: RHHBY). Shares of Alexion jumped as high as $120.48, or 10.2 percent on the news. More than 2.5 million...